skip to main content

Listen

Read

Watch

Schedules

Programs

Events

Give

Account

Donation Heart Ribbon

UC San Diego Study Links Cholesterol-Lowering Statins To Fatigue

Evening Edition

Above: Drs. Beatrice Golomb and Mimi Guarneri talk to KPBS about the Statin study published in the current issue of Archives of Internal Medicine.

Aired 6/12/12 on KPBS Midday Edition.

Guests

Beatrice Golomb, MD, PhD, associate professor of medicine at UC San Diego School of Medicine. Dr Golomb is lead researcher of the Statin Study published in the current issue of Archives of Internal Medicine.

Dr. Mimi Guarneri is the founder and the medical director of the Scripps Center for Integrative Medicine

Transcript

UC San Diego researchers find another downside to drugs that control bad cholesterol. The drugs are the popular statins like Lipitor and Crestor. The new study finds that the drugs can cause fatigue, especially if you're trying to increase physical exercise.
Enlarge this image

Above: UC San Diego researchers find another downside to drugs that control bad cholesterol. The drugs are the popular statins like Lipitor and Crestor. The new study finds that the drugs can cause fatigue, especially if you're trying to increase physical exercise.

Aired 6/11/12 on KPBS News.

Widely prescribed cholesterol-lowering statin drugs cause fatigue at rest and during exercise, suggests a new double-blind study from UC San Diego.

In a randomized study of 1,000 adults, researchers found patients who take generic and brand name statin drugs like Lipitor, Zocor, Crestor and others are much more likely to experience fatigue while at rest and during exertion.

Severe fatigue or loss of energy can impact long term physical health and patient compliance in taking the drugs, said Dr. Beatrice Golomb, the lead researcher of the study and an associate professor of medicine at UC San Diego School of Medicine

“This side effect, which is fairly common, does bear consideration in determining whether to use these drugs, specifically if the risks outweigh the benefits,” said Golomb.

Drug dosage was also important in the reported energy levels of patients, especially for women in the study.

“Side effects of statins generally rise with increasing dose; the doses we examined were modest by current standards,” Golomb said.

Her data also showed fatigue greatly impacted “interest in physical activity” and was considered “central to quality of life” by study participants.

In February, concern over rare, but serious, risk of liver damage, memory loss and diabetes led the FDA to require additional safety warnings on statin drug labels.

The statin-fatigue study was published in the June 11th issue of Archives of Internal Medicine.